X-Chem

X-Chem, Inc. is a privately held biotechnology company located in Waltham, Massachusetts, founded in 2009. The company specializes in discovering small molecule leads targeting high-value therapeutic areas through its innovative DNA-Encoded Library (DEL) technology. X-Chem's approach involves the iterative combinatorial synthesis of small molecules, which are linked to DNA tags that document their synthetic history. This method enhances the efficiency and effectiveness of drug discovery, enabling the generation of novel small molecule therapeutics.

David Hagerman

CFO

David Werry

Director

1 past transactions

lntelliSyn

Acquisition in 2021
IntelliSyn providers of medicinal chemistry support in North America. Our team of experienced scientists (>80% PhD), at our state-of-the-art facilities in Montreal, specializes in identifying novel leads and optimizing them as successful clinical candidates for our collaborators across Major Pharma and Biotech. IntelliSyn provide discovery support (computational chemistry, design, synthesis, and DMPK) where innovation, intellectual property security, and proven delivery-expertise are needed on an expert basis. Our discipline expertise ranges across CNS, oncology, metabolic diseases as well as other specialized areas including structure-based design, GPCR modulators, and ion channel modulators.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.